Please click here to view this emailer online
HHM Global Nedwsletter
Power Info Today Linkedin Page Power Info Today Facebook Page Power Info Today Twitter Page Weekly Newsletter
Click here to subscribe to our newsletter
Himss australia 2017
Top Latest Press Releases
Medical fair thailand 2017 reflects the bullish growth of the Medical industry

Medical fair thailand 2017 reflects the bullish growth of the Medical industry in the region

This year edition of MEDICAL FAIR THAILAND is set to be its biggest yet with more than 700 international exhibitors expected. 17 national and country pavilions will present more than 5,000 state-of-the-art medical...


Vomaris Technology Impacts Biofilm-Induced Antibiotic Resistance

Vomaris Innovations, Inc. announced a notable presentation of clinically relevant data on how exposure to electric fields generated by their Advanced Microcurrent Technology disrupts biofilm-induced antibiotic resistance at the Symposium...


Michigan Medicine ranks in 90th percentile for diabetes performance

Michigan Medicine has ranked in the 90th percentile of the AMGA Foundation Diabetes: Together 2 Goal campaign for its diabetes performance related to lipid management. The campaign, launched in March 2016, has a goal to improve care for 1 million people...

Philips digital pathology gets a first FDA nod for primary diagnostic use

Philips digital pathology system gets a first FDA nod for primary diagnostic use

Royal Philips has received regulatory clearance from the U.S. FDA to market its IntelliSite Pathology Solution, a comprehensive digital pathology system designed to meet the challenges of pathology lab..


Illumina Launches the VeriSeq NIPT Solution in Europe

Illumina, Inc. announced the launch of the VeriSeq NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT), including CE-IVD marked library prep and analysis software...


FDA approves two of Gilead hepatitis C drugs for pediatric patients

Gilead Sciences, Inc announced that the U.S. FDA has approved supplemental indications for Harvoni (ledipasvir 90 mg/sofosbuvir 400 mg) tablets and Sovaldi (sofosbuvir 400 mg) tablets for the treatment of chronic hepatitis C virus (HCV) infection...


Phone: + 91 84476 12124

For the latest visit: